2Weinreb NJ,Charrow J,Andersson HC,et al.Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment:a report from the Gaucher Rigistry.Am J Med,2002,113:112-119.
3Charrow J,Andersson HC,Kaplan P,et al.Enzyme replacement therapy and monitoring for children with type 1 Gaucher disease:consensus recommendations.J Pediatr,2004,114:116.
4Barton NW,Brady RO,Dambrosia JM,et al.Replacement therapy for inherited enzyme deficiency:Macrophage-targeted glucocerebrosidase for Gaucher's disease.N Engl J Med,1991,324:1464-1470.
5Beutler E,Kay A,Saven A,et al.Enzyme replacement therapy for gaucher disease.Blood,1991,78:1183-1189.
6Brady RO.Enzyme replacement therapy:conception,chaos and culmination.Phil Trans R Soc Lond B,2003,358:915-916.
7Grabowski GA,Barton NW,Pastores G,et al.Enzyme therapy in type 1 Gaucher disease:comparative efficacy of mannose-terminated,glucocerebrosidase from natural and recombinant sources.Ann Intern Med,1995,122:33-39.
8Pastores G,Sibille AR,Grabowski GA.Enzyme therapy in Gaucher disease type 1; dosage,efficasy,and adverse effects in 33 patients treated for 6 to 24 months.Blood,1993,82:408-416.
9Grabowski GA,Leslie N,Wenstrup RJ.Enzyme therapy for Gaucher disease:the first 5 years.Blood Rev,1998,12:115-133.
10Grabowski GA.Recent clinical progress in Gaucher disease.Curr Opin Pediatr,2005,17:519-524.
